Cold-to-Hot Tumor Conversion Program

About FindImmune

FindImmune is a private, preclinical-stage biotech developing novel immuno-oncology therapies. Its core strategy involves stimulating the immune system for anticancer vaccination and overcoming tumor resistance by modulating the tumor microenvironment, particularly through targeting macrophage checkpoints. As a spin-off from the prestigious Gustave Roussy institute, it benefits from deep scientific expertise and a partnered discovery platform. The company is pre-revenue and aims to advance its lead candidates into the clinic to address significant unmet needs in oncology.

Therapeutic Areas

Other Cancer Drugs